Fri, Jul 25, 2014, 8:24 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Venaxis, Inc. Message Board

jrdelane 818 posts  |  Last Activity: 36 minutes ago Member since: Dec 5, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • jrdelane jrdelane Apr 26, 2014 11:39 PM Flag

    Who here has been adding shares during this stage of the breakdown? The 10 year chart this is about as oversold as it has ever been. History would (as stated in hdno's post here) favor long trades. I would never have thought we'd see these levels, nor do I believe anyone else who posts here would have. Last week I added at $2.75, but just don't want to get more committed. Who is adding?

    Sentiment: Hold

  • Reply to

    Seeing a Trend

    by new2nvesting Apr 25, 2014 10:23 AM
    jrdelane jrdelane Apr 27, 2014 11:46 AM Flag

    Are you at all worried about the Nasdaq continuing to sell off? lately, we've correlated closely to this index. Holding stocks long into (the possibility of) a broad market 'major' correction is daunting, then add the complexities of this one being so volatile anyway with the Vidara deal closing in a few months, short term gains, and then the likely sell off after earnings. Looks like you sold then bought back in?

  • Reply to

    Seeing a Trend

    by new2nvesting Apr 25, 2014 10:23 AM
    jrdelane jrdelane Apr 27, 2014 7:59 PM Flag

    Thanks TG, shrewd way to evaluate the market, whether it rewards great companies providing good quarterly results and guidance. Been watching chart of DDD and ALNY, neck and neck corrections. Like 'EM both but haven't room for either. Been buying GALE and ELTP lately for the long haul. Gale was up yesterday, ELTP held flat last week. I too think the market will have a good second half, but that isn't enough to be sure. We should do very well here, but I look to guys like you for confirmation.

  • jrdelane jrdelane Apr 27, 2014 9:00 PM Flag

    He's done very well in his business life to afford that much investment here, and ATRS is likely worthy of his and our investment. It is time however for the best side of Antares to finally reveal itself, prove its value for once, there's been a lot of faith and money invested here. While we sit under $3.00 which I find to be insulting, I'm done growing my position. I see better risk reward elsewhere, even cash has outperformed ATRS these past two years. Like I said, it is high time ATRS proves it is worthy of our attention and money. And as far as Wotten is concerned, his reputation as a CEO has become greatly diminished in my view, he hasn't delivered and when he reports, the stock tanks.

  • Reply to

    I just averaged

    by richmei12 Apr 25, 2014 12:21 PM
    jrdelane jrdelane Apr 27, 2014 9:25 PM Flag

    Good move. Keep adding in here while you can. I did, and plan to keep doing so. Holding 70,000 now, will add 30k more this week. I like that the share price held this recent gain under pressure in the broad and bio market. She will break $1.00 on the next leg of the rise, quite confident in holding and adding to this one. Also GALE, last week it broke out of it's down trending channel. Good luck!

    Sentiment: Strong Buy

  • Reply to

    NLNK earnings better than expected GOING UP

    by robertvilato Apr 24, 2014 10:42 AM
    jrdelane jrdelane Apr 27, 2014 9:36 PM Flag

    Only if Nasdaq and IBB stop hemorrhaging. If that be the case, it's got a shot at doing 30 by July. Market isn't rewarding companies which don't have good revenues now or later this year. Witness ALNY, ARWR, other developmental biotechs.

    Sentiment: Hold

  • Reply to

    THE TRADES

    by ny.investor Apr 27, 2014 9:44 PM
    jrdelane jrdelane Apr 28, 2014 12:05 AM Flag

    NY, I'm loving it, how fast and emphatically the sentiment has changed to all out bullish from a week ago. I agree this thing could rip to $4.00 or more this week as shorts and longs are both trying to buy shares! I was adding last week, even AH, and now want to major add to my stake. Thanks for your steady input here, you're doing a great job!

    Sentiment: Strong Buy

  • Reply to

    How much will Glaxo pay to take out Vical ?

    by blackbart1880 Apr 26, 2014 7:16 PM
    jrdelane jrdelane Apr 28, 2014 12:29 AM Flag

    What makes you post such a question? Who says they might be interested?

  • Reply to

    Tempest in Teapot...

    by play_tow Apr 27, 2014 5:28 PM
    jrdelane jrdelane Apr 28, 2014 2:13 AM Flag

    If Sanofi wasn't going to do a launch until late 2014 anyway, this won't really hurt POZN other than the cost to deal with fda's specific issues, it can be approved in a matter of months. If it's just a manufacturing CRL with our state of the art vendor, it's a lock the drug is approved. It just gives longs a chance to buy more cheaper shares without risk of PA being disapproved as a drug. I had a starter position anyway, so now I can fill it out on any weakness and look for my long term gains in 2015. Not a big deal, hold your shares longs!

  • jrdelane jrdelane Apr 28, 2014 2:29 AM Flag

    Also a first case showed up in Egypt, saw the article today in The Seattle Sunday Times. Fear of it jumping borders is real.

  • jrdelane jrdelane Apr 28, 2014 2:45 AM Flag

    Tigerw1234, no one here told you to buy without first doing your own DD, if you are referring to the sentiment at the bottom, that is "log term sentiment" indicator of the poster. Never buy something new all at once unless you are an experienced investor, average into you position over weeks or months giving time between each lot purchased. That way you average in so you're less likely to overpay. Hold if you're in too strong. BTW, I am also underwater here, a result of doubling my position just prior to all recent events that have impacted share price negatively (R/S, share offering, Nasdaq and IBB consolidation, silent period by Company). Good luck, we have plenty of company I'm sure!

    Sentiment: Hold

  • Gale has done a yeoman's lifting here in the last week, and stayed positive when the whole market was under pressure. We saw a nice lift earlier today, some sold into it, good for you. I have my eyes down the road and know when better market days are ahead, this stock will rocket back to a true value and the news is only going to keep getting better. We still may close positive on the day, hold a good thought.

    Sentiment: Buy

  • Reply to

    Good news was still good news, gains erased

    by jrdelane Apr 28, 2014 1:29 PM
    jrdelane jrdelane Apr 28, 2014 1:37 PM Flag

    I just added 3,000 shares at 2.29, I think its a penny lower now, but I know what I've got here and it's going to be very good once this market gets past this rough spot. Even if it doesn't the news and forward catalysts will stimulate a buying frenzy, especially as the short covering kicks in. This is a great time to add if you have any dry powder. My long term sentiment is buy, my average share price is 2.70, so I am down some, not at all worried.

    Sentiment: Buy

  • Reply to

    $2.75 by friday

    by theman3311 Apr 28, 2014 1:44 PM
    jrdelane jrdelane Apr 28, 2014 1:48 PM Flag

    To think that today you can own shares .66 less than those who participated in the recent offering, that is how good these share prices are, due to the biotech sector rotation, and the silent period by the Company. I know the R/S has weighed on the share price as well, but this Company is going to have results later this year that will put the share price much, much higher and I'm going to protect my shares and wait out this dip. Good luck longs!

    Sentiment: Strong Buy

  • No part of me is comfortable looking at ATRS at today's price. I am unconvinced that it's a good buy, but it doesn't seem like a sell either. The good post today by dpca10 on the Medac vs Antares suit is somewhat reassuring, but with court cases, you can't assume it's a non-event, so the cloud lingers--it will take time to resolve. Technically, ATRS is a 96% strong sell, Barchart says so based on their 14 technical indicators. Historically, we all know it's in the buy range, but can one apply last years metrics and come up with the same conclusions as to it being a great value in here? I can't. Loko has long questioned the trademark name being protected, and his post today (whether he's a short trying to bash or not) is another cloud over the launch because changing trade names mid launch if forced to do so, would take away from everything they've established to this point. My last buy was at 2.75 when it retraced back over $3.00 the same or next day. This time it is reached organically, in a gradual falling pattern. I am holding, not adding, extending my timeframe for the shares to recover. Never thought I'd see these levels, good luck to all longs.

    Sentiment: Hold

  • Reply to

    IBB at key 200 dma

    by topgunbioinvestor Apr 28, 2014 11:54 AM
    jrdelane jrdelane Apr 28, 2014 3:24 PM Flag

    We're back to even on the day with IBB, what a roller coaster! I think I saw 12.90 intra-day on HZNP, now 13.46. Didn't buy, didn't sell, driving us all a bit crazy isn't it, so hard to trade with confidence in here with the broad market and IBB giving us cross signals.

    Sentiment: Buy

  • Reply to

    I just averaged

    by richmei12 Apr 25, 2014 12:21 PM
    jrdelane jrdelane Apr 28, 2014 3:51 PM Flag

    I picked up another 10,000 shares today, didn't get the low but .39 is a good price, considering where we'll be in a year, two or five years down the road with ART technology is adopted by many of the major providers of opiods. I don't know of a better risk reward out there, now holding 80,000 shares.

    Sentiment: Strong Buy

  • There has been a new filing today, about 20 minutes ago, indicating that there is an omission in the 10Q protected by this CT order. Anyone have any clue on this?

    Sentiment: Strong Buy

  • Reply to

    Never thought I do this

    by jerrycurls81 Apr 28, 2014 1:00 PM
    jrdelane jrdelane Apr 28, 2014 4:04 PM Flag

    We were down .23 to 2.19 and now only .08 at 2.33. Today we may have put in the lows for IBB and this whole biotech sector out-rotation. I too am a a bagholder, but have taken profits along the way, still have my eyes on the prize and have resisted selling into weakness. There are two stocks where I like the risk and reward in here, both are trending up last and this week. GALE and ELTP. Added shares of both today. Good luck longs!

    Sentiment: Hold

  • Reply to

    Zacks Bio Analyst twit

    by usma67korea Apr 28, 2014 4:27 PM
    jrdelane jrdelane Apr 28, 2014 5:00 PM Flag

    Confirming what our inside analyst PB has been saying, nice to see it come from an external source, thanks for sharing. Jason has long followed POZN, so he's keep track of this from their side.

APPY
1.93-0.01(-0.52%)Jul 25 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.